Stay updated on Pembrolizumab Combo in Resectable NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Location labels updated to use 'Respublika' instead of 'Republic' (e.g., 'Tatarstan Republic Locations' -> 'Tatarstan, Respublika Locations'; 'Kazan, Tatarstan Republic, Russia, 420029' -> 'Kazan, Tatarstan, Respublika, Russia, 420029'); version bumped to v3.0.2; 'Back to Top' removed.
    Difference
    0.2%
    Check dated 2025-09-13T01:45:50.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.
    Difference
    0.1%
    Check dated 2025-09-05T19:55:49.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of numerous facility locations across various countries and the inclusion of drug information for multiple medications, while some previous location entries and drug-related topics have been removed.
    Difference
    21%
    Check dated 2025-08-29T16:37:08.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.0%
    Check dated 2025-08-15T10:33:13.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.0%
    Check dated 2025-08-08T08:54:53.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.4%
    Check dated 2025-08-01T05:12:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Resectable NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page.